Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387409968> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4387409968 abstract "Anakinra is a recombinant interleukin-1 (IL-1) receptor antagonist used in systemic juvenile idiopathic arthritis (sJIA), refractory Kawasaki disease (KD) and cryopyrin-associated autoinflammatory syndrome (CAPS). Anakinra associated hepatotoxicity, while rare, has been described in several cases in daily practice. In this case series the authors describe three pediatric patients with this side effect in the setting of severe macrophage activation syndrome (MAS) in KD and sJIA.The first patient was a 12-year-old boy who presented with fever, maculo-papular exanthema and polyarthralgia. Tonsillitis, distal limb induration and tender cervical lymph nodes were observed. Erythrocyte-sedimentation rate (ESR), C-reactive protein (CRP), ferritin (11,975 ng/mL), D-dimers (5,98 mg/L FEU) and soluble CD25 (3645 pg/mL) levels were elevated. Exclusion of sepsis / toxic shock syndrome warranted introduction of IV methylprednisolone and immunoglobulin (IG IV), with partial response. A MAS secondary to KD was assumed, and anakinra 2 mg/kg/day was introduced. Twenty days later he developed new-onset nausea and severe cyto-cholestasis, normalizing after 2 months of drug discontinuation. Posterior onset of polyarthritis and evanescent lead to a final diagnosis of sJIA. The second patient was a 2-year-old boy with a 10-day history of fevers, generalized rash, hepatosplenomegaly and strawberry tongue. Leucocytosis with neutrophilia and elevated CRP were observed. Initial treatment with IVIG in the setting of incomplete KD was ineffective. Mild anaemia, leukopenia and very high serum ferritin (maximum 26,128 ng/mL) ensued. Presumptive sJIA associated MAS was treated with IV methylprednisolone and anakinra 2 mg/kg/day, with prompt response. Four weeks later transaminitis was detected, and temporary anakinra suspension led to normalisation of laboratorial values. The third case related to a 4-year-old boy presenting with fever, maculopapular rash and cervical lymphadenopathy. CRP and ESR were elevated, and KD was diagnosed. IVIG and methylprednisolone were initiated with clinical worsening, warranting for anakinra introduction at 2 mg/kg/day. After three weeks, liver enzymes progressively elevated, resolving on 2 weeks of anakinra discontinuation.To the best of our knowledge, this is the first case series describing anakinra associated hepatotoxicity in pediatric patients with rheumatic diseases other than sJIA, bringing additional insight to therapeutic monitoring in patients undergoing this treatment." @default.
- W4387409968 created "2023-10-07" @default.
- W4387409968 creator A5029790428 @default.
- W4387409968 creator A5036359989 @default.
- W4387409968 creator A5069719271 @default.
- W4387409968 creator A5073434187 @default.
- W4387409968 creator A5074772621 @default.
- W4387409968 creator A5082000278 @default.
- W4387409968 date "2023-10-06" @default.
- W4387409968 modified "2023-10-11" @default.
- W4387409968 title "Anakinra and hepatotoxicity in pediatric rheumatology: a case series" @default.
- W4387409968 cites W1505537322 @default.
- W4387409968 cites W1865524649 @default.
- W4387409968 cites W2045625161 @default.
- W4387409968 cites W2149275181 @default.
- W4387409968 cites W2160267599 @default.
- W4387409968 cites W2225832060 @default.
- W4387409968 cites W2795863563 @default.
- W4387409968 cites W2987255949 @default.
- W4387409968 cites W3083598351 @default.
- W4387409968 cites W3097506707 @default.
- W4387409968 cites W3129423277 @default.
- W4387409968 cites W4210350996 @default.
- W4387409968 cites W4307633667 @default.
- W4387409968 doi "https://doi.org/10.1186/s12969-023-00891-y" @default.
- W4387409968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37803456" @default.
- W4387409968 hasPublicationYear "2023" @default.
- W4387409968 type Work @default.
- W4387409968 citedByCount "0" @default.
- W4387409968 crossrefType "journal-article" @default.
- W4387409968 hasAuthorship W4387409968A5029790428 @default.
- W4387409968 hasAuthorship W4387409968A5036359989 @default.
- W4387409968 hasAuthorship W4387409968A5069719271 @default.
- W4387409968 hasAuthorship W4387409968A5073434187 @default.
- W4387409968 hasAuthorship W4387409968A5074772621 @default.
- W4387409968 hasAuthorship W4387409968A5082000278 @default.
- W4387409968 hasBestOaLocation W43874099681 @default.
- W4387409968 hasConcept C126322002 @default.
- W4387409968 hasConcept C17991360 @default.
- W4387409968 hasConcept C198451711 @default.
- W4387409968 hasConcept C2776820930 @default.
- W4387409968 hasConcept C2777077863 @default.
- W4387409968 hasConcept C2777226972 @default.
- W4387409968 hasConcept C2777363875 @default.
- W4387409968 hasConcept C2778143017 @default.
- W4387409968 hasConcept C2778570526 @default.
- W4387409968 hasConcept C2778616394 @default.
- W4387409968 hasConcept C2779134260 @default.
- W4387409968 hasConcept C2779382419 @default.
- W4387409968 hasConcept C2779440204 @default.
- W4387409968 hasConcept C2779613421 @default.
- W4387409968 hasConcept C2780007613 @default.
- W4387409968 hasConcept C2780372218 @default.
- W4387409968 hasConcept C2781228260 @default.
- W4387409968 hasConcept C2781423770 @default.
- W4387409968 hasConcept C71924100 @default.
- W4387409968 hasConcept C90924648 @default.
- W4387409968 hasConceptScore W4387409968C126322002 @default.
- W4387409968 hasConceptScore W4387409968C17991360 @default.
- W4387409968 hasConceptScore W4387409968C198451711 @default.
- W4387409968 hasConceptScore W4387409968C2776820930 @default.
- W4387409968 hasConceptScore W4387409968C2777077863 @default.
- W4387409968 hasConceptScore W4387409968C2777226972 @default.
- W4387409968 hasConceptScore W4387409968C2777363875 @default.
- W4387409968 hasConceptScore W4387409968C2778143017 @default.
- W4387409968 hasConceptScore W4387409968C2778570526 @default.
- W4387409968 hasConceptScore W4387409968C2778616394 @default.
- W4387409968 hasConceptScore W4387409968C2779134260 @default.
- W4387409968 hasConceptScore W4387409968C2779382419 @default.
- W4387409968 hasConceptScore W4387409968C2779440204 @default.
- W4387409968 hasConceptScore W4387409968C2779613421 @default.
- W4387409968 hasConceptScore W4387409968C2780007613 @default.
- W4387409968 hasConceptScore W4387409968C2780372218 @default.
- W4387409968 hasConceptScore W4387409968C2781228260 @default.
- W4387409968 hasConceptScore W4387409968C2781423770 @default.
- W4387409968 hasConceptScore W4387409968C71924100 @default.
- W4387409968 hasConceptScore W4387409968C90924648 @default.
- W4387409968 hasIssue "1" @default.
- W4387409968 hasLocation W43874099681 @default.
- W4387409968 hasLocation W43874099682 @default.
- W4387409968 hasOpenAccess W4387409968 @default.
- W4387409968 hasPrimaryLocation W43874099681 @default.
- W4387409968 hasRelatedWork W1806733851 @default.
- W4387409968 hasRelatedWork W1968969296 @default.
- W4387409968 hasRelatedWork W2009248078 @default.
- W4387409968 hasRelatedWork W2033672237 @default.
- W4387409968 hasRelatedWork W2043790076 @default.
- W4387409968 hasRelatedWork W2076186742 @default.
- W4387409968 hasRelatedWork W2364154505 @default.
- W4387409968 hasRelatedWork W2583202494 @default.
- W4387409968 hasRelatedWork W3014388424 @default.
- W4387409968 hasRelatedWork W4206594664 @default.
- W4387409968 hasVolume "21" @default.
- W4387409968 isParatext "false" @default.
- W4387409968 isRetracted "false" @default.
- W4387409968 workType "article" @default.